NPM1 and acute myeloid leukemia: Considering our recently uncovered sensing mechanism of NPM1 in response to nucleolar stress 31, we strongly expect that the chemical compounds that enable NPM1 glutathionylation or specifically target the NPM1 nucleic acid binding site would exert better efficacy in therapies for malignancies like NPM1c+ AML.